Impax Laboratories buy klostergang
Start price
21.09.17
/
50%
€21.38
Target price
07.05.18
€31.57
Performance (%)
-22.78%
End price
07.05.18
€16.51
Summary
This prediction ended on 07.05.18 with a price of €16.51. The price of Impax Laboratories has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -22.78%. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Impax Laboratories | - | - | - | - |
| iShares Core DAX® | 3.075% | 0.488% | 11.388% | 50.357% |
| iShares Nasdaq 100 | 2.876% | 0.081% | 22.472% | 81.104% |
| iShares Nikkei 225® | 5.981% | 3.033% | 41.000% | 59.466% |
| iShares S&P 500 | 2.231% | 0.046% | 18.100% | 60.472% |
Comments by klostergang for this prediction
In the thread Impax Laboratories diskutieren
klostergang stimmt der fundamentalen Bewertung mit dem Ergebnis 'überbewertet' nicht zu
Rumor du jour: Impax Labs mulling merger with Amneal Pharma
A deal could be announced as early as next month. A takeover could boost Impax's value north of $2B
(Vom Mitglied beendet)